Author: admin

Chronic Rhinosinusitis with Nasal Polyps Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | AstraZeneca, Amgen, Keymed Biosciences, GlaxoSmithKline

The Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Market size was valued approximately USD 1,837 million in 2022 and the report offers an in-depth understanding of the Chronic Rhinosinusitis with Nasal Polyps, historical and forecasted epidemiology as well as the Chronic Rhinosinusitis with Nasal Polyps market trends in the 7MM.

DelveInsight’s “Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Chronic Rhinosinusitis with Nasal Polyps, historical and forecasted epidemiology as well as the Chronic Rhinosinusitis with Nasal Polyps market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

 

To Know in detail about the Chronic Rhinosinusitis with Nasal Polyps market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Chronic Rhinosinusitis with Nasal Polyps Market Forecast

 

Some of the key facts of the Chronic Rhinosinusitis with Nasal Polyps Market Report: 

  • The Chronic Rhinosinusitis with Nasal Polyps market size was valued approximately USD 1,837 million in 2022 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
  • In 2022, the collective number of prevalent cases of Chronic Rhinosinusitis (CRS) in the 7MM was identified as 69,871,809 cases, with an anticipated substantial Compound Annual Growth Rate (CAGR) projected throughout the study period spanning from 2019 to 2032.
  • In 2022, the overall identified prevalent cases of Chronic Rhinosinusitis (CRS) in the 7MM were determined to be 18,063,335. Projections indicate a notable Compound Annual Growth Rate (CAGR) for these cases during the forecast period spanning from 2023 to 2032.
  • In 2022, the 7MM recorded a total of 4,381,214 diagnosed prevalent cases of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), with an anticipated increase expected over the study period.
  • In 2022, the United States reported the highest number of diagnosed prevalent cases of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) within the 7MM, reaching 2,191,303 cases. The gender distribution reveals a male predominance in the US, with 55% of the diagnosed prevalent cases of CRSwNP being males.
  • In 2022, the European Union 4 (EU4) and the United Kingdom collectively represented 1,987,545 diagnosed prevalent cases of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). This accounted for 45% of the total diagnosed prevalent cases of CRSwNP in the 7MM.
  • Key Chronic Rhinosinusitis with Nasal Polyps Companies: AstraZeneca, Amgen, Keymed Biosciences, GlaxoSmithKline, Genentech, Inc, Novartis, Upstream Bio Inc., Regeneron Pharma, Genrix (Shanghai) Biopharmaceutical, Guangdong Hengrui Pharmaceutical, Keymed Biosciences Co.Ltd, and others
  • Key Chronic Rhinosinusitis with Nasal Polyps Therapies: FASENRA (benralizumab), Tezepelumab, CM310, GSK3511294 (depemokimab), Omalizumab, Xolair, Verekitug (UPB-101), Dupilumab SAR231893, GR1802 injection, SHR-1905 Injection, CM310, and others
  • The Chronic Rhinosinusitis with Nasal Polyps epidemiology based on gender analyzed that in 2022, out of the total diagnosed prevalent cases of CRSwNP in 7MM about 57% were male.
  • The Chronic Rhinosinusitis with Nasal Polyps market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage CRSwNP pipeline products will significantly revolutionize the Chronic Rhinosinusitis with Nasal Polyps market dynamics.

 

Chronic Rhinosinusitis with Nasal Polyps Overview

Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is a chronic inflammatory condition of the nasal passages and sinuses characterized by the presence of benign growths called nasal polyps. This condition involves persistent inflammation of the nasal and sinus mucosa, leading to the development of soft, non-cancerous growths within the nasal and sinus cavities.

 

Get a Free sample for the Chronic Rhinosinusitis with Nasal Polyps Market Forecast, Size & Share Analysis Report: 

https://www.delveinsight.com/report-store/chronic-rhinosinusitis-with-nasal-polyps-crswnp-market

 

Chronic Rhinosinusitis with Nasal Polyps Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Chronic Rhinosinusitis with Nasal Polyps Epidemiology Segmentation:

The Chronic Rhinosinusitis with Nasal Polyps market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Chronic Rhinosinusitis with Nasal Polyps
  • Prevalent Cases of Chronic Rhinosinusitis with Nasal Polyps by severity
  • Gender-specific Prevalence of Chronic Rhinosinusitis with Nasal Polyps
  • Diagnosed Cases of Episodic and Chronic Chronic Rhinosinusitis with Nasal Polyps

 

Download the report to understand which factors are driving Chronic Rhinosinusitis with Nasal Polyps epidemiology trends @ Chronic Rhinosinusitis with Nasal Polyps Epidemiology Forecast

 

Chronic Rhinosinusitis with Nasal Polyps Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Chronic Rhinosinusitis with Nasal Polyps market or expected to get launched during the study period. The analysis covers Chronic Rhinosinusitis with Nasal Polyps market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Chronic Rhinosinusitis with Nasal Polyps Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Chronic Rhinosinusitis with Nasal Polyps Therapies and Key Companies

  • FASENRA (benralizumab): AstraZeneca
  • Tezepelumab: AstraZeneca/Amgen
  • CM310: Keymed Biosciences
  • GSK3511294 (depemokimab): GlaxoSmithKline
  • Omalizumab: Genentech, Inc
  • Xolair: Novartis
  • Verekitug (UPB-101): Upstream Bio Inc.
  • Dupilumab SAR231893: Regeneron Pharmaceuticals
  • GR1802 injection: Genrix (Shanghai) Biopharmaceutical
  • SHR-1905 Injection: Guangdong Hengrui Pharmaceutical
  • CM310: Keymed Biosciences Co.Ltd

 

Discover more about therapies set to grab major Chronic Rhinosinusitis with Nasal Polyps market share @ Chronic Rhinosinusitis with Nasal Polyps Treatment Landscape

 

Chronic Rhinosinusitis with Nasal Polyps Market Strengths

  • There is a growing focus on biologics to expand providers’ arsenal in treating patients. • The coveted approvals of NUCALA and XOLAIR in the overall existing treatment have added effectiveness intreating CRSwNP.

 

Chronic Rhinosinusitis with Nasal Polyps Market Opportunities

  • About half of the CRSwNP patients do not know the cause of their symptoms, so strategic procedures to target this patient population are expected to uplift the overall market.
  • There are opportunities for cost-effective treatment options for severe recurrent CRSwNP patients.

 

Scope of the Chronic Rhinosinusitis with Nasal Polyps Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Chronic Rhinosinusitis with Nasal Polyps Companies: AstraZeneca, Amgen, Keymed Biosciences, GlaxoSmithKline, Genentech, Inc, Novartis, Upstream Bio Inc., Regeneron Pharma, Genrix (Shanghai) Biopharmaceutical, Guangdong Hengrui Pharmaceutical, Keymed Biosciences Co.Ltd, and others
  • Key Chronic Rhinosinusitis with Nasal Polyps Therapies: FASENRA (benralizumab), Tezepelumab, CM310, GSK3511294 (depemokimab), Omalizumab, Xolair, Verekitug (UPB-101), Dupilumab SAR231893, GR1802 injection, SHR-1905 Injection, CM310, and others
  • Chronic Rhinosinusitis with Nasal Polyps Therapeutic Assessment: Chronic Rhinosinusitis with Nasal Polyps current marketed and Chronic Rhinosinusitis with Nasal Polyps emerging therapies
  • Chronic Rhinosinusitis with Nasal Polyps Market Dynamics: Chronic Rhinosinusitis with Nasal Polyps market drivers and Chronic Rhinosinusitis with Nasal Polyps market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Chronic Rhinosinusitis with Nasal Polyps Unmet Needs, KOL’s views, Analyst’s views, Chronic Rhinosinusitis with Nasal Polyps Market Access and Reimbursement 

 

To know more about Chronic Rhinosinusitis with Nasal Polyps companies working in the treatment market, visit @ Chronic Rhinosinusitis with Nasal Polyps Clinical Trials and Therapeutic Assessment

 

Table of Contents 

1. Chronic Rhinosinusitis with Nasal Polyps Market Report Introduction

2. Executive Summary for Chronic Rhinosinusitis with Nasal Polyps

3. SWOT analysis of Chronic Rhinosinusitis with Nasal Polyps

4. Chronic Rhinosinusitis with Nasal Polyps Patient Share (%) Overview at a Glance

5. Chronic Rhinosinusitis with Nasal Polyps Market Overview at a Glance

6. Chronic Rhinosinusitis with Nasal Polyps Disease Background and Overview

7. Chronic Rhinosinusitis with Nasal Polyps Epidemiology and Patient Population

8. Country-Specific Patient Population of Chronic Rhinosinusitis with Nasal Polyps 

9. Chronic Rhinosinusitis with Nasal Polyps Current Treatment and Medical Practices

10. Chronic Rhinosinusitis with Nasal Polyps Unmet Needs

11. Chronic Rhinosinusitis with Nasal Polyps Emerging Therapies

12. Chronic Rhinosinusitis with Nasal Polyps Market Outlook

13. Country-Wise Chronic Rhinosinusitis with Nasal Polyps Market Analysis (2019–2032)

14. Chronic Rhinosinusitis with Nasal Polyps Market Access and Reimbursement of Therapies

15. Chronic Rhinosinusitis with Nasal Polyps Market Drivers

16. Chronic Rhinosinusitis with Nasal Polyps Market Barriers

17.  Chronic Rhinosinusitis with Nasal Polyps Appendix

18. Chronic Rhinosinusitis with Nasal Polyps Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About DelveInsight 

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Chronic Rhinosinusitis with Nasal Polyps Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | AstraZeneca, Amgen, Keymed Biosciences, GlaxoSmithKline

FASTCASH4IPHONES Makes It Easy For People To Sell Their iPhones And Make Fast Money

FASTCASH4IPHONES Makes It Easy For People To Sell Their iPhones And Make Fast Money
FASTCASH4IPHONES offers the best solution to those looking to sell their iPhones and quickly make some easy money.

FASTCASH4IPHONES, a leading buyer and seller of brand-name consumer electronic products is dedicated to providing stress-free service to individuals seeking to sell their devices for fast payment. Those in need of quick funds can rely on this platform to sell their phones swiftly and without any complications.

“We understand that people may need extra funds and want to sell their devices quickly,” says Andrew Kim, founder of FASTCASH4IPHONES. “Time is money, and we prioritize getting our customers paid promptly and at a good and reasonable price. In addition to serving individual sellers, we also work with businesses and stores to buy devices in bulk, providing convenient solutions for liquidating inventory.”

FASTCASH4IPHONES buys phones from all popular brands, including Apple, Samsung, Google, Nintendo, Sony, LG, Dyson, and Microsoft. They specialize in offering a seamless selling experience for a wide range of products, including iPhones, iPads, galaxies, MacBooks, iMacs, iWatches, AirPods, Surface Pros, and more.

FASTCASH4IPHONES remains committed to offering efficient and reliable device-selling solutions, ensuring a positive experience for every customer.

For a hassle-free selling experience, individuals can simply visit the FASTCASH4IPHONES website, click the ‘Sell Your Device’ button, and provide the necessary details about their old smartphones. Once the device’s condition and specifications are submitted, an instant quote is generated, making the process quick and straightforward.

The company upholds a fair deal policy and competitive pricing guarantee, ensuring customers receive a just deal for their old devices. If the device matches the details and passes the inspection, customers receive their agreed-upon payment promptly without any price haggling or negotiation. The offer remains valid for seven days.

The device must be shipped to the company’s warehouse using the shipping label generated. The customer must make sure the product is packaged safely and securely.

The payment is made via Cash App, Venmo, Zelle, Paypal, Crypto, Apple Pay, or cash for those who are local.

People looking to sell their old devices can contact the company via phone or email and get a free quote instantly.

For more information, visit www.Fastcash4iphones.com

Follow their Facebook Page at facebook.com/fastcash4iphones and Instagram at @fastcash4iphones 

About FASTCASH4IPHONES

FASTCASH4IPHONES is a reputable buyer and seller of brand-name consumer electronic products. The company offers quick and hassle-free solutions for individuals looking to sell their devices. Focusing on excellent service and prompt payments, FASTCASH4IPHONES provides a convenient selling experience for customers. Currently, they service the Los Angeles/Orange County/San Bernardino area. Their office is located in Ontario, CA.

Media Contact
Company Name: FASTCASH4IPHONES
Contact Person: Andrew Kim
Email: Send Email
Phone: 714 900 2242
Address:12223 Highland Ave 564
City: Rancho Cucamonga
State: CA
Country: United States
Website: www.Fastcash4iphones.com

Parkinson’s Disease Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | AbbVie, Mitsubishi Tanabe Pharma (NeuroDerm), Cerevance, Amneal

The Parkinson’s Disease Market size was valued approximately USD 3,226 million in 2022 and the report offers an in-depth understanding of the Parkinson’s Disease, historical and forecasted epidemiology as well as the Parkinson’s Disease market trends in the 7MM.

DelveInsight’s “Parkinson’s Disease Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Parkinson’s Disease, historical and forecasted epidemiology as well as the Parkinson’s Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

 

To Know in detail about the Parkinson’s Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Parkinson’s Disease Market Forecast

 

Some of the key facts of the Parkinson’s Disease Market Report: 

  • The Parkinson’s Disease market size was valued approximately USD 3,226 million in 2022 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
  • In 2022, the United States recorded the highest number of diagnosed prevalent cases of Parkinson’s disease, totaling approximately 1,152,195 cases, while Italy reported the lowest incidence, with nearly 152,237 cases.
  • In 2022, Parkinson’s disease affected approximately 660,458 males and 491,736 females in the United States. It is projected that the prevalence of the disease will continue to rise by 2032.
  • In 2022, Germany recorded the highest number of diagnosed prevalent cases of Parkinson’s disease among EU4 and the UK countries, totaling around 454,448 cases. France followed with approximately 264,695 cases in the same year.
  • The analysis suggests that approximately 501,726 cases were diagnosed among individuals aged over 75 years. The majority of cases occur in the elderly population.
  • In 2022, the highest prevalence was observed in the stage III group, comprising 587,965 cases, followed by stage IV with 269,729 cases. It is anticipated that the number of cases will rise in the forecast period.
  • Key Parkinson’s Disease Companies: AbbVie, Mitsubishi Tanabe Pharma (NeuroDerm), Cerevance, Amneal Pharmaceutical, Pharma Two B, Jazz Pharmaceuticals, Chase Therapeutics Corporation, Mthera Pharma Co., Ltd., Bial R&D Investments, S.A., Hoffmann-La Roche, NeuroDerm Ltd., Tasly Pharmaceutical, BrainX Corporation, UCB Biopharma SRL, National Neuroscience Institute, GE Healthcare, Cerevel Therapeutics, LLC, Inhibikase Therapeutics, Inc., Bial – Portela C S.A., Neuraly, Inc., Forest Hills Lab, Intra-Cellular Therapies, Inc., FAScinate Therapeutics Inc., AC Immune SA, and others
  • Key Parkinson’s Disease Therapies: ABBV-951, ND0612, CVN-424, IPX203, P2B001, Suvecaltamide (JZP385), CTC-413, MT101-5, BIA 28-6156, RO7046015, ND0612, pimavanserin tartrate, Ceftriaxone, UCB0599, Tocovid Suprabio (HOV-12020), Altropane (123I) Injection, Tavapadon, IkT-148009, Opicapone, NLY01, Gemfibrozil, Lenrispodun, KM-819, ACI-7104.056, and others
  • The Parkinson’s Disease epidemiology based on gender analyzed that there is male preponderance in the Parkinson’s disease cases in the 7MM
  • The Parkinson’s Disease market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Parkinson’s Disease pipeline products will significantly revolutionize the Parkinson’s Disease market dynamics.

 

Parkinson’s Disease Overview

Parkinson’s disease is a neurodegenerative disorder that primarily affects movement. It is characterized by a progressive loss of neurons in the brain, particularly in a region called the substantia nigra, which is responsible for producing dopamine, a neurotransmitter involved in movement control.

 

Get a Free sample for the Parkinson’s Disease Market Forecast, Size & Share Analysis Report: 

https://www.delveinsight.com/report-store/parkinsons-disease-market-size-analysis-treatment

 

Parkinson’s Disease Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Parkinson’s Disease Epidemiology Segmentation:

The Parkinson’s Disease market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Parkinson’s Disease
  • Prevalent Cases of Parkinson’s Disease by severity
  • Gender-specific Prevalence of Parkinson’s Disease
  • Diagnosed Cases of Episodic and Chronic Parkinson’s Disease

 

Download the report to understand which factors are driving Parkinson’s Disease epidemiology trends @ Parkinson’s Disease Epidemiology Forecast

 

Parkinson’s Disease Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Parkinson’s Disease market or expected to get launched during the study period. The analysis covers Parkinson’s Disease market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Parkinson’s Disease Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Parkinson’s Disease Therapies and Key Companies

  • ABBV-951: AbbVie
  • ND0612: Mitsubishi Tanabe Pharma(NeuroDerm)
  • CVN-424: Cerevance
  • IPX203: Amneal Pharmaceutical
  • P2B001: Pharma Two B
  • Suvecaltamide (JZP385): Jazz Pharmaceuticals
  • CTC-413: Chase Therapeutics Corporation
  • MT101-5: Mthera Pharma Co., Ltd.
  • BIA 28-6156: Bial R&D Investments, S.A.
  • RO7046015: Hoffmann-La Roche
  • ND0612: NeuroDerm Ltd.
  • pimavanserin tartrate: Tasly Pharmaceutical
  • Ceftriaxone: BrainX Corporation
  • UCB0599: UCB Biopharma SRL
  • Tocovid Suprabio (HOV-12020): National Neuroscience Institute
  • Altropane (123I) Injection: GE Healthcare
  • Tavapadon: Cerevel Therapeutics, LLC
  • IkT-148009: Inhibikase Therapeutics, Inc.
  • Opicapone: Bial – Portela C S.A.
  • NLY01: Neuraly, Inc.
  • Gemfibrozil: Forest Hills Lab
  • Lenrispodun: Intra-Cellular Therapies, Inc.
  • KM-819: FAScinate Therapeutics Inc.
  • ACI-7104.056: AC Immune SA

 

Discover more about therapies set to grab major Parkinson’s Disease market share @ Parkinson’s Disease Treatment Landscape

 

Parkinson’s Disease Market Drivers

  • Growing research and development are increasing the demand for better diagnosis and treatment options for Parkinson’s Disease.
  • In recent years, drugs with a novel mechanism of action and combinations are being investigated to overcome the challenges of this entity

 

Parkinson’s Disease Market Barriers

  • The development of a disease-modifying drug can potentially increase the Parkinson’s Disease market share potential.
  • In advanced countries, there is a huge annual psychological, social, and economic burden (QALY) due to Parkinson’s Disease.

 

Scope of the Parkinson’s Disease Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Parkinson’s Disease Companies: AbbVie, Mitsubishi Tanabe Pharma (NeuroDerm), Cerevance, Amneal Pharmaceutical, Pharma Two B, Jazz Pharmaceuticals, Chase Therapeutics Corporation, Mthera Pharma Co., Ltd., Bial R&D Investments, S.A., Hoffmann-La Roche, NeuroDerm Ltd., Tasly Pharmaceutical, BrainX Corporation, UCB Biopharma SRL, National Neuroscience Institute, GE Healthcare, Cerevel Therapeutics, LLC, Inhibikase Therapeutics, Inc., Bial – Portela C S.A., Neuraly, Inc., Forest Hills Lab, Intra-Cellular Therapies, Inc., FAScinate Therapeutics Inc., AC Immune SA, and others
  • Key Parkinson’s Disease Therapies: ABBV-951, ND0612, CVN-424, IPX203, P2B001, Suvecaltamide (JZP385), CTC-413, MT101-5, BIA 28-6156, RO7046015, ND0612, pimavanserin tartrate, Ceftriaxone, UCB0599, Tocovid Suprabio (HOV-12020), Altropane (123I) Injection, Tavapadon, IkT-148009, Opicapone, NLY01, Gemfibrozil, Lenrispodun, KM-819, ACI-7104.056, and others
  • Parkinson’s Disease Therapeutic Assessment: Parkinson’s Disease current marketed and Parkinson’s Disease emerging therapies
  • Parkinson’s Disease Market Dynamics: Parkinson’s Disease market drivers and Parkinson’s Disease market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Parkinson’s Disease Unmet Needs, KOL’s views, Analyst’s views, Parkinson’s Disease Market Access and Reimbursement 

 

To know more about Parkinson’s Disease companies working in the treatment market, visit @ Parkinson’s Disease Clinical Trials and Therapeutic Assessment

 

Table of Contents 

1. Parkinson’s Disease Market Report Introduction

2. Executive Summary for Parkinson’s Disease

3. SWOT analysis of Parkinson’s Disease

4. Parkinson’s Disease Patient Share (%) Overview at a Glance

5. Parkinson’s Disease Market Overview at a Glance

6. Parkinson’s Disease Disease Background and Overview

7. Parkinson’s Disease Epidemiology and Patient Population

8. Country-Specific Patient Population of Parkinson’s Disease 

9. Parkinson’s Disease Current Treatment and Medical Practices

10. Parkinson’s Disease Unmet Needs

11. Parkinson’s Disease Emerging Therapies

12. Parkinson’s Disease Market Outlook

13. Country-Wise Parkinson’s Disease Market Analysis (2019–2032)

14. Parkinson’s Disease Market Access and Reimbursement of Therapies

15. Parkinson’s Disease Market Drivers

16. Parkinson’s Disease Market Barriers

17.  Parkinson’s Disease Appendix

18. Parkinson’s Disease Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About DelveInsight 

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Parkinson’s Disease Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | AbbVie, Mitsubishi Tanabe Pharma (NeuroDerm), Cerevance, Amneal

Siddhesh Suryakant Dongare Recognized as Agile Coach of the Year at India Agile Awards 2024

Siddhesh Suryakant Dongare, a distinguished Agile coach and inventor of Agile iteration for data mining (AIP-DM), has been honoured with the prestigious Agile Coach of the Year award at the India Agile Awards 2024. The award ceremony, organized by UNICOM, took place in Bangalore, recognizing excellence in Agile practices within the industry.

Siddhesh Suryakant Dongare’s approach to Agile coaching is rooted in deep expertise and innovation. His invention of Agile iteration for data mining (AIP-DM) reflects his commitment to developing practical solutions that drive efficiency and effectiveness in Agile practices.

In addition to being a certified Agility Coach with credentials including CAL-E®, CAL-T®, CAL-O®, PAL-EBM®, and ICP-ENT®, Siddhesh holds certifications as a PMI PMP® and PMI ACP®, SAFe® 5.1 Scrum Master, and Certified Lean Six Sigma practitioner. His diverse skill set underscores his comprehensive understanding of project management and Agile methodologies.

Siddhesh Suryakant Dongare is also a published author, known for the book “Shape Your Life by Changing Perspective,” which emphasizes the importance of personal growth and transformation and He was honored as the winner of the Business Mint Nationwide Awards Under 40 Entrepreneurs & Industry Experts in 2024 for his work on the book “Shape Your Life by Changing Perspective.”

The India Agile Awards 2024, attended by industry leaders from companies such as Accenture, Allianz Technologies, Google, Barclays, Renault Nissan (RNTBCI), and Fidelity International, recognized Siddhesh Suryakant Dongare’s achievements alongside other outstanding professionals in the field of Agile coaching.

The assessment process for the Agile Coach of the Year award involved a thorough review of Siddhesh’s contributions and impact within the Agile community, highlighting his dedication to fostering Agile principles and driving innovation in product and project management.

For more information about India Agile Awards 2024, please visit https://www.unicomlearning.com/2024/India_Agile_Awards/

 

Siddhesh Dongare is also the author of “Shape Your Life by Changing Perspective”. 

Learn more at: https://shiftlifeperspective.com/

Connect with Siddhesh Suryakant Dongare on Social Media:

LinkedIn: https://www.linkedin.com/in/agile-practitioner-coach/

Instagram: https://www.instagram.com/dongare_siddhesh/

Media Contact
Company Name: CB Herald
Contact Person: Ray
Email: Send Email
City: Bengaluru
State: Karnataka
Country: India
Website: www.linkedin.com/in/agile-practitioner-coach/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Siddhesh Suryakant Dongare Recognized as Agile Coach of the Year at India Agile Awards 2024

Leawo Released Prof. Media V13.0.0.3 to Add Multi-track MP4/MKV Output for UHD Ripper/Blu-ray Ripper and Fix Known Bugs

Shenzhen, Guangdong, China – April 22, 2024 – Leawo Software, a leading multimedia software developer and provider, is pleased to announce the release of Leawo Prof. Media V13.0.0.3. This new version brings significant enhancements to its UHD Ripper and Blu-ray Ripper modules, adding multi-track MP4/MKV output formats, as well as other improvements and bug fixes.

Key Updates in Leawo Prof. Media V13.0.0.3:

  1. Added HEVC 10bit HDR10 MP4/MKV Output Formats: The UHD Ripper module now supports the latest video output formats including HEVC 10bit HDR10 MP4/MKV. This allows users to enjoy high-quality video playback with enhanced color and contrast.

  2. Added Common Multi-track MP4/MKV Output Formats: Both UHD Ripper and Blu-ray Ripper modules have been upgraded to support multi-track MP4/MKV output formats. This update ensures that users can retain multiple audio tracks and subtitles in the converted video, providing a seamless and versatile viewing experience.

  3. Added 24bit FLAC Output Format: Leawo has added a new output format to the UHD Ripper and Blu-ray Ripper modules. With 24bit FLAC output format, users can enjoy high-quality audio that preserves the original sound quality.

  4. Added VP9 Video Codec in WEBM Format: The Convert function in Leawo Prof. Media now supports the VP9 video codec in the WEBM format. This addition expands the options for video conversion and ensures compatibility with modern video standards.

  5. Updated to Retain Chapter Info for Blu-ray to DVD Module: Users can now enjoy a more convenient experience when converting Blu-ray to DVD, as the new version retains chapter information during the conversion process.

  6. Fixed Known Bugs: In addition to these new features, the latest version also addresses and fixes known bugs, providing users with a smoother and more reliable software experience.

Leawo Prof. Media is one of the main flagships of Leawo Software, which owns multiple brands including Leawo, Moyea, CleverGet, etc. It is a comprehensive multimedia processing toolkit that combines several modules for video and audio conversion, Blu-ray and DVD ripping, disc burning, video downloading, and more. With the addition of the new features in V13.0.0.3, Leawo Prof. Media enables users to take advantage of even more flexible and high-quality options for their multimedia needs.

About Leawo Software

Leawo Software is a leading multimedia software developer and provider that specializes in developing high-quality multimedia solutions for global customers. Its products range from video, audio, and DVD/Blu-ray tools to mobile and online applications, with a commitment to providing the best user experience.

Media Contact
Company Name: Leawo Software
Contact Person: Steven Zhang Chief Executive Officer
Email: Send Email
Phone: +86-755-26553081
City: Shenzhen
State: Guangdong
Country: China
Website: www.leawo.org

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Leawo Released Prof. Media V13.0.0.3 to Add Multi-track MP4/MKV Output for UHD Ripper/Blu-ray Ripper and Fix Known Bugs

Spice Bazaar: Pioneering the New Era of Indian Cuisine in New Jersey

Westfield, NJ – In the bustling heart of Westfield, New Jersey, a culinary revolution is quietly simmering. Spice Bazaar, a local Indian restaurant, is quickly setting itself apart as a beacon of innovation in the culinary landscape. With an ethos centered on continuous evolution and adaptation to modern dining trends, Spice Bazaar aims to not just participate in New Jersey’s vibrant restaurant scene but to lead it by redefining what Indian cuisine can be.

From its inception, the restaurant has embraced a philosophy of dynamic change, ensuring that its offerings always reflect both the timelessness of Indian culinary traditions and the pulse of contemporary taste preferences. The menu is a living entity, regularly updated and refined to blend the old with the new, crafting a niche of its own in the process. This approach has transformed Spice Bazaar into more than just a dining destination; it has become a progressive movement in the Indian dining scene.

At Spice Bazaar, tradition meets innovation on every plate. The restaurant has taken up the challenge of pushing the boundaries of traditional Indian recipes by introducing innovative dishes that resonate with a diverse clientele. These creations are more than just meals; they are a form of communication, conveying stories and building bridges between cultures through flavors and spices meticulously chosen to both comfort and surprise the palate.

The strategy goes beyond mere ingredients and recipes. It’s about reimagining the Indian dining experience altogether, making it more interactive and enjoyable. This means designing an atmosphere where every visit becomes an immersive journey into the depths of Indian culture, presented with a modern twist that appeals to a broad audience. Guests at Spice Bazaar can expect not only a meal but an experience that engages all senses.

This commitment to innovation is matched by an unwavering dedication to quality. Every dish served is a reflection of a quest for perfection, employing only the finest ingredients and the most authentic techniques honed over generations, yet always with a nod to modern culinary trends. This balance of old and new has garnered a dedicated following, making Spice Bazaar a community cornerstone where food lovers gather not just for the flavors but for the shared experience that comes with every visit.

The restaurant’s impact extends beyond its doors. It acts as a vibrant center of community activity, fostering a gathering space for those who appreciate groundbreaking approaches to traditional dining. The commitment to providing a unique dining experience is evident in every aspect of the restaurant, from the decor that whispers of faraway lands to the plating that showcases the artistry inherent in Indian cuisine.

As Spice Bazaar continues to thrive, the mission remains clear: to ensure that every spice and every flavor not only delights but also tells a tale. It is this narrative approach to cooking and serving food that positions Spice Bazaar at the forefront of the Indian restaurant scene in New Jersey. Every meal served is an adventure, an exploration of what Indian cuisine can offer when it’s not afraid to reinvent itself.

Looking to the future, Spice Bazaar is committed to maintaining its role as a leader in culinary innovation. The restaurant’s journey is marked by a fearless approach to experimentation and a keen sensitivity to the desires of its patrons. It is this combination that promises to keep Spice Bazaar at the cutting edge, continually evolving and adapting, much like the vibrant flavors that dance across its menu.

As Spice Bazaar sets its sights on becoming the best restaurant in New Jersey, it invites diners to be part of this exciting journey, to come and experience the magic of a cuisine that respects its roots while daring to dream about its future possibilities.

About Spice Bazaar:

Located in the heart of Westfield, New Jersey, Spice Bazaar is renowned for its innovative approach to Indian cuisine, combining traditional dishes with modern culinary concepts to create a unique dining experience. Committed to excellence and continuous innovation, Spice Bazaar is at the forefront of redefining Indian dining in the Garden State.

Media Contact
Company Name: Spice Bazaar | Modern Indian Dining
Contact Person: Simran Bakshi
Email: Send Email
Address:39 elm st
City: Westfield
State: NJ 07090
Country: United States
Website: www.SpiceBazaarNJ.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Spice Bazaar: Pioneering the New Era of Indian Cuisine in New Jersey

Popular TikTok Duo Debuts in Tampa Florida with a One Night Only Theatrical Variety Play

Written and produced by the viral duo, this event celebrates Dance and LGBTQ at Centro Asturiano de Tampa on Friday, May 31, 2024.

On May 31, 2024, Tampa, FL is set to witness a first-of-its-kind event as the highly anticipated variety show “It’s Time For Love” debuts at the Centro Asturiano de Tampa. Written and directed by Cristen Appleton, a former competitive gymnast turned Latin Ballroom, Salsa, Bachata, and West Coast Swing dancer, this show promises an evening of emotion, laughter, and stunning performances. 

Cristen gained fame during the pandemic with viral videos featuring her dancing around her 7-foot-tall husband, Jason Appleton, a popular YouTuber, which garnered over 32 million views.

The play follows Horatio, a brilliant inventor, and entrepreneur who has been the mastermind behind many of the leading innovations of his time, struggles to fill the void in his heart, and spends all of his nights alone, wondering and wishing.

Desperate to find a solution to his loneliness, he fiercely attacks his newest technology and creates a Time Machine, in which he sends Winston, his loyal assistant, through time to collect the most beautiful and talented women to come back and perform and vie for Horatio’s love.

There may be a few hiccups along the way, as Winston’s nervous nature and fumbling hands may land him in some interesting situations. Nonetheless, he continues his faithful quest, taking the audience on an exciting ride of love, heartache, and comedic relief.

With a diverse ensemble featuring acts from Drag, Aerial, Vocal, Paso Doble, Salsa, and Pole Dancing, this thrilling show is full of powerful emotions and mesmerizing performances.

”Be drawn in by the story and mesmerized by the performances for a thrilling show that pulls on many emotions, leaving you wanting more,” Cristen Appleton remarked. “This one-night-only production will inspire you, make you laugh, and ultimately bring you to tears and you will love every moment of it. A true passion project with a message of love and acceptance.”

Tickets for It’s Time For Love” are now on sale for $25, $45, and $65 at TonOfApples.com. Interested personals are requested to book their favorite seats at the earliest. The show starts at 8 PM EST.

CAST:

Robert Fowler as Horatio

Camila Rose as Caliope

Cristen Appleton as Cristina

Larissa Oliviera as Fatima

Clinton Hughes as Winston

Christy Parker as Astrid

Nick Cochran as Launna

Joanne Togati as Isabella

Kushina Hicks as Francesca

Find more info at:

Theater: https://www.centroasturianotampa.org/theatre

Facebook: https://www.facebook.com/profile.php?id=61557577295234

Tiktok: https://www.tiktok.com/@cristenappleton

Learn more about Cristen and Jason at https://www.dailymail.co.uk/femail/article-12839445/Couple-TWO-FOOT-height-difference-relationship.html

Media Contact
Company Name: Ton Of Apples Entertainment
Contact Person: Cristen Appleton
Email: Send Email
Phone: 513-706-2680
City: Tampa
State: Florida
Country: United States
Website: tonofapples.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Popular TikTok Duo Debuts in Tampa Florida with a One Night Only Theatrical Variety Play

Quito Leads Revolutionary Shift in Environmental Activism with Landmark Legal Strategy

Quito, Ecuador – In a remarkable transformation of environmental activism, Quito, the capital city of Ecuador, has positioned itself at the forefront of a global movement by adopting a groundbreaking legal approach to combat the environmental threats posed by mining. The grassroots collective “Quito sin Minería” (Quito without Mining) has spearheaded this innovative shift, moving away from traditional protest methods towards leveraging the power of Ecuadorian law to defend their environment and community.

This new method marks a significant departure from conventional activism, which often involved public demonstrations and direct confrontations. By embracing a legal strategy that utilizes the constitution and legal frameworks to their advantage, Quito sin Minería has established a precedent in using legal tools for environmental protection, setting an inspiring example for communities worldwide.

Strategic Use of Legal Frameworks

The cornerstone of Quito sin Minería’s approach is their strategic use of legal mechanisms originally designed to regulate mining operations. These laws have been transformed into effective tools against unsustainable mining practices, highlighting a novel method of advocacy that relies on intellectual and legal expertise rather than physical protests.

This strategic legal approach reached a pivotal milestone with the initiation of the first citizen-led referendum in Ecuador’s history, targeting the cessation of detrimental mining activities. This historic referendum not only underscored the effectiveness of Quito sin Minería’s methods but also the critical role of civic engagement in influencing environmental policy.

Empowering the Community Through Education

A key to the success of Quito sin Minería has been their dedication to educating the local population about their rights and the legal pathways available to protect their environment. Through workshops, seminars, and public forums, the collective has transformed community members from passive observers into informed and active participants in environmental governance.

Global Implications and Future Directions

Quito sin Minería’s victory extends beyond local achievements, serving as a blueprint for other communities facing threats from exploitative industrial activities. Their model demonstrates how legal strategies and active civic participation can lead to significant environmental victories, emphasizing the importance of legal literacy and community involvement in advocacy.

The Road Ahead: A Focus on Sustainable Practices and Policy Improvement

Moving forward, Quito sin Minería aims to continue their advocacy by focusing on promoting sustainable development and strengthening environmental legislation. Their ongoing efforts are geared towards ensuring that the victories achieved are preserved and that environmental protection remains a priority in policy discussions both in Ecuador and globally.

A Global Call to Action

The success of Quito sin Minería is a clarion call to communities around the world, illustrating the power of legal knowledge and collective action in shaping a sustainable future. As environmental challenges continue to escalate globally, the collective’s achievements inspire hope and encourage communities everywhere to engage in informed, strategic activism.

About Quito sin Minería:

Quito sin Minería is a grassroots collective committed to environmental justice and community empowerment. Comprising legal experts, environmental activists, and concerned citizens, the group endeavors to prevent mining encroachments in Quito through strategic legal actions and robust public engagement.

Conclusion

As Quito sin Minería continues to pioneer new methods in environmental activism, their use of legal strategies to safeguard the environment is redefining activism for the modern era. Their example serves as a powerful reminder of the impact that knowledge, legal acumen, and collective action can have in creating a more sustainable and equitable world.

For further information about Quito sin Minería’s initiatives, or to learn more about how you can support their cause, please contact the provided contact details.

Media Contact
Company Name: Maruri
Contact Person: Tabatha Loor
Email: Send Email
Address:1420 ne Miami Pl
City: Miami
State: FL 33132
Country: United States
Website: www.sorrygeorge.org

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Quito Leads Revolutionary Shift in Environmental Activism with Landmark Legal Strategy

Lonesome George: A Legacy Transformed from Conservation Icon to Champion of Diversity

Once known only as the last of his kind, Lonesome George, the Galapagos giant tortoise who captured the hearts of conservationists around the world, is now posthumously recognized as a symbol of diversity and inclusion. Diálogo Diverso, a leading advocacy group for the LGBTIQ+ community in Ecuador, is spearheading this transformative recognition with significant implications for animal behavior understanding and zoo management globally.

Despite his death in 2012 at over 100 years of age, Lonesome George’s story continues to evolve. Best known for his role as the last known individual of the Pinta Island tortoise species, George was a focal point in international conservation efforts. However, recent discussions initiated by Diálogo Diverso have shed light on another aspect of his life—his potential preference for partners of the same gender, a fact that was overlooked due to longstanding biases in animal behavioral studies.

In a heartfelt public apology to Lonesome George, Diálogo Diverso expressed regret that he might have been misunderstood and misrepresented by the very people who sought to protect him. The group proposed that the failure to recognize and facilitate his natural behavior could have contributed to his failure to reproduce, adding a poignant layer to his solitude.

Following this public statement, Diálogo Diverso launched a global petition urging zoological parks and conservation bodies worldwide to acknowledge and support natural same-gender behavior in animals. This initiative advocates for a paradigm shift in how animal relationships are viewed and managed in captivity, arguing that recognizing these behaviors is crucial for the well-being and psychological health of all zoo inhabitants.

The narrative of Lonesome George is not just a tale of conservation but also a narrative about recognizing diversity in all its forms. By advocating for a change in how we interpret and support animal behavior, we honor George’s legacy and challenge the status quo of animal care and conservation.

This expanded interpretation of George’s life highlights the intersectionality of conservation and social justice, suggesting that the principles of inclusivity and equality should extend beyond human society and into how we treat other species. This initiative positions Lonesome George as a bridge between diverse biological behaviors and broader societal acceptance.

The petition also calls for educational programs in zoos that inform the public about the naturalness of same-gender behavior in numerous species, fostering a more informed and compassionate understanding of wildlife. This educational effort is seen as a critical step in building empathy and supporting ethical conservation practices that respect animal autonomy and natural behavior.

The success of this movement relies not only on zoo management but also on public support and understanding. We must all be willing to learn and embrace the natural complexities of the animals we aim to protect.

As the petition gains traction among conservationists and the public, the broader implications for zoological and environmental policies are profound. By advocating for changes that respect animal diversity in behaviors, Diálogo Diverso hopes to influence global standards for animal welfare and conservation.

Furthermore, this movement seeks to catalyze a broader shift towards inclusivity in all areas of society, using Lonesome George’s story as a rallying point for those who advocate for recognizing and celebrating diversity in every community, whether human or animal.

As this initiative unfolds, zoos and conservationists are encouraged to reflect on their practices and consider how an expanded understanding of animal behavior could not only prevent the misunderstandings of the past but also lead to more compassionate conservation efforts in the future.

Zoological parks across the globe are now faced with the decision to embrace this call to action. The response to this initiative will not only affect the legacy of Lonesome George but could set new precedents for how zoos contribute to a more just and inclusive society.

Media Contact
Company Name: Maruri
Contact Person: Tabatha Loor
Email: Send Email
Phone: (786) 516 – 1397
Address:1420 ne Miami Pl
City: Miami
State: FL 33132
Country: United States
Website: www.sorrygeorge.org

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Lonesome George: A Legacy Transformed from Conservation Icon to Champion of Diversity

Canadian Neurocosmetic Society Launched by Dr. Reza Ghalamghash to Pioneer Integrative Research in Beauty and Neuroscience

“Canadian Neurocosmetic Society Founded to Pioneer Advancements in Neurocosmetic Research and Application”
Dr. Reza Ghalamghash has established the Canadian Neurocosmetic Society (CNS) to advance research and application at the intersection of neuroscience and cosmetic science. The CNS aims to foster innovation, educate professionals and the public, and promote the integration of scientific research into cosmetic practices for enhanced mental and physical well-being.

Toronto, Canada – April, 22, 2024 – Dr. Reza Ghalamghash, a renowned figure in the field of neurocosmetics, is proud to announce the establishment of the Canadian Neurocosmetic Society (CNS). This new society aims to bridge the gap between neuroscience and cosmetic science, promoting innovative research and application in the enhancement of beauty and wellness.

The CNS is dedicated to fostering a multidisciplinary approach in the study and development of neurocosmetic products and therapies. By integrating the latest scientific research and technological advancements, the society seeks to provide groundbreaking solutions that enhance both mental and physical well-being through cosmetic practices.

Main Goals of the Canadian Neurocosmetic Society:- Promote Research and Development: Encourage rigorous scientific research and innovation in the neurocosmetic field.- Educational Initiatives: Provide training and continuous education opportunities for professionals in the cosmetics and neuroscience fields.- Public Awareness and Engagement: Increase public understanding of the benefits and potential of neurocosmetics through seminars, publications, and community outreach.

Dr. Ghalamghash stated, “The founding of the Canadian Neurocosmetic Society marks a significant step towards merging cutting-edge neuroscience with cosmetic applications to improve quality of life. Our mission is to establish standards, educate professionals and the public, and foster innovations that meet the highest scientific and ethical standards.”

The CNS will be collaborating with academic institutions, industry leaders, and policymakers to ensure that the potential of neurocosmetics is fully realized and beneficial to all. Membership and partnership opportunities are available for those who wish to contribute to and benefit from the society’s initiatives.

For more information about the Canadian Neurocosmetic Society, its goals, and upcoming events, please visit [neurocosmetic.ca] (http://neurocosmetic.ca). Interested parties can also contact Dr. Reza Ghalamghash directly via email at Reza@neurocosmetic.ca

Contact:

Dr. Reza Ghalamghash, Founder

Canadian Neurocosmetic Society

Email: Reza@neurocosmetic.ca

Website: [neurocosmetic.ca] (http://neurocosmetic.ca)

Media Contact
Company Name: canadian neurocosmetic society
Contact Person: Reza Ghalamghash
Email: Send Email
Phone: 9056040802
Address:7080 Warden Ave b3
City: Markham
State: Ontario
Country: Canada
Website: neurocosmetic.ca

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Canadian Neurocosmetic Society Launched by Dr. Reza Ghalamghash to Pioneer Integrative Research in Beauty and Neuroscience